National Institute of Allergy and Infectious Diseases; Amended Notice of Closed Meeting
---
identifier: "/us/fr/2022-23540"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Institute of Allergy and Infectious Diseases; Amended Notice of Closed Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2022-23540"
section_name: "National Institute of Allergy and Infectious Diseases; Amended Notice of Closed Meeting"
positive_law: false
currency: "2022-10-28"
last_updated: "2022-10-28"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2022-23540"
document_type: "notice"
publication_date: "2022-10-28"
agencies:
- "Health and Human Services Department"
- "National Institutes of Health"
fr_citation: "87 FR 65215"
fr_volume: 87
---
# National Institute of Allergy and Infectious Diseases; Amended Notice of Closed Meeting
Notice is hereby given of a change in the meeting of the National Institute of Allergy and Infectious Diseases Special Emphasis Panel NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) which was published in the *Federal Register* on September 30, 2022, FR Doc 2022-21261, 87 FR 59446.
Amendment to change meeting date from October 26, 2022, to November 14, 2022. The meeting is closed to the public.
Dated: October 25, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.